Skip to main content
. 2020 May 27;20:798. doi: 10.1186/s12889-020-08930-z

Table 1.

Characteristics of the Segments

Segments ANOVA or Kruskal-
Wallis/χ2 test
1 2 3 4 5 6 7 8 9 10 Population value
Care Utilisation, mean (SD)
 Non-elective inpatient admissions 0.01 (0.1)z 0.17 (0.41)x 1.27 (0.54)x 3.27 (1.68)x 0.02 (0.15)y 0.34 (0.55)x 0.35 (0.69)x 0.02 (0.13) 1.25 (1.29)x 0 (0)z 0.14 (0.52) KW: < 0.000
 Elective inpatient admissions 0 (0) 1.22 (0.54)x 0.03 (0.16)x 0.36 (0.65)x 0 (0) 0.14 (0.36)y 0.1 (0.37)y 0 (0) 0.14 (0.43)z 0 (0.02) 0.08 (0.34) KW: < 0.000
 Outpatient first attendances 0 (0)x 0.87 (0.88)y 0.39 (0.6)x 1.79 (1.82)x 1.23 (0.52)y 1.89 (1.19)y 1.26 (1.17)y 0.17 (0.39)x 0.92 (1.13)y 0.09 (0.3)x 0.34 (0.72) KW: < 0.000
 Outpatient follow-up attendances 0.14 (0.71)x 2.02 (2.39)x 1.17 (1.85)y 4.22 (4.69)y 1.17 (1.92)y 3.66 (3.03)y 20.53 (12.98)x 0.79 (1.52)x 2.26 (3.96)x 0.26 (0.92)x 0.91 (2.98) KW: < 0.000
 GP practice visits 0.11 (0.4)x 1.34 (1.56)y 1.3 (1.28)y 4.94 (3.54)x 0.93 (1.06)x 4.6 (2.29)x 1.55 (2.05)z 0.71 (1.02)x 7.55 (3.28)x 0.81 (0.99)x 0.74 (1.51) KW: < 0.000
 Prescribing (Distinct Drug Count) 1.78 (2.04)x 8.11 (6.39)y 6.65 (5.64)x 15.9 (10.01)z 4.31 (3.61)x 15 (7.92)z 8.28 (7.62)y 12.35 (4.58)z 20.64 (9.23)x 2.61 (2.77)x 4.75 (5.8) KW: < 0.000
 A&E attendances, mean (SD) 0 (0)x 0.48 (0.81)x 1.52 (1.02)y 5.13 (3.15)x 0.28 (0.49)x 1.13 (1.22)x 0.69 (1.12)x 0.14 (0.39)x 2.04 (1.93)y 1.46 (0.84)x 0.41 (0.95) KW: < 0.000
Patient characteristics
 Age, mean (SD) 36.2 (21.5)x 53.6 (20.5)x 38.2 (27.9)x 47.5 (27.3)x 42.9 (23)y 59.3 (21.4)y 42.1 (20.3)y 60.4 (18.5)y 82.1 (11.1)x 29.8 (20)x 41.4 (23.7) AN: < 0.000
 Quintile 1 & 2 Deprivation, % 84.2 85.7 87.6 88.6 85.0 85.2 86.5 86.1 78.5z 85.6 85.0 χ2: < 0.000
 Current smoker, % 20.3 23.1 22.3 27.2 22.1 22.1 28.0 25.9z 12.8x 20.6 21.6 χ2: < 0.000
 Risk of emergency admission in next 12 months, mean (SD) 0.07 (0.05)x 0.27 (0.13)x 0.23 (0.14)y 0.45 (0.19) 0.2 (0.1)y 0.38 (0.15) 0.36 (0.16)z 0.24 (0.12)x 0.5 (0.17)z 0.12 (0.08)x 0.15 (0.13) AN: < 0.000
Long Term Conditions (LTCs)
 Number of LTCs, mean (SD) 0.58 (0.92)y 2.55 (2.36)x 2.08 (2.44)x 5.27 (4.03)y 1.22 (1.46)x 3.75 (2.68)y 2.31 (2.45)x 2.89 (1.95)x 6.46 (3.39)x 0.64 (1)y 1.32 (1.9) KW: < 0.000
 Long Term Condition, prevalence in %
  ARMD 0.2y 1.6 0.9z 1.9 0.7z 2.8z 2.2 1.9 9.0x 0.2z 0.7 χ2: < 0.000
  Arthritis 0.2z 1.2 1.2 2.6z 0.8 5.0y 1.2 2.4z 5.7y 0.3z 0.9 χ2: < 0.000
  Asthma 7.1y 15.7 13.6 24.6z 10.3z 21.3z 16.2 21.9z 11.8 9.6z 11.0 χ2: < 0.000
  Bipolar Disorder 0.1z 0.4 0.5 2.7z 0.4 1.3z 2.5z 0.8 1.4 0.1 0.4 χ2: < 0.000
  CHF 0.1z 1.8z 2.1 8.4x 0.5z 4.8x 2.2 2.6z 14.9x 0.1z 1.0 χ2: < 0.000
  COPD 0.7y 7.1z 6.3z 20.6x 2.0x 12.9y 6.5z 12.2y 30.7x 0.5y 3.6 χ2: < 0.000
  CRF 1.1y 6.7z 5.7z 15.7y 3.2y 13.1y 5.6 10.8x 31.0x 0.8y 3.8 χ2: < 0.000
  Depression 6.8x 15.4 13.5 28.7y 11.9y 17.7 17.2 16.8 22.0 8.5x 10.3 χ2: < 0.000
  Diabetes 2.1y 11.7y 8.2x 21.7 5.3x 25.4 13.3y 24.9 24.8 1.9y 7.1 χ2: < 0.000
  Glaucoma 0.5y 3.4 1.5 2.8 1.3 4.5y 2.0 3.2 9.5x 0.3y 1.3 χ2: < 0.000
  Hypertension 9.5x 33.4x 22.8y 39.2x 17.8y 46.6x 21.0z 49.5x 68.1x 7.2x 18.9 χ2: < 0.000
  Hyperthyroidism 1.8y 7.4y 4.9z 11.1z 4.1z 11.7z 5.2 11.5z 17.5x 1.6y 4.2 χ2: < 0.000
  Ischaemic Heart Ds 0.6y 7.6z 6.8z 19.8y 2.6y 17.5y 5.1 11.7x 30.0x 0.8y 3.8 χ2: < 0.000
  Low Back Pain 1.1y 5.1 3.6 8.8y 2.2z 5.8z 2.8 4.4 5.4 2.0z 2.3 χ2: < 0.000
  Osteoporosis 0.0z 0.8z 1.4y 5.8y 0.3 2.1x 0.7 0.4 7.1y 0.0 0.4 χ2: < 0.000
  Parkinson’s Ds. 0.0 0.1 0.4 1.1 0.3 1.1y 0.2 0.5 5.0x 0.0 0.2 χ2: < 0.000
  Schizophrenia 0.4z 0.8 1.6z 4.6y 0.9z 2.3y 10.7x 1.3 4.5y 0.3z 0.9 χ2: < 0.000
  Seizure Disorder 0.8 2.1z 4.0z 10.4x 1.2 3.4 2.2 3.0 4.7 1.3 1.6 χ2: < 0.000

Significantly different from all 9 other segments; y: Significantly different from 8 other segments; z: Significantly different from 7 other segments; All at 0.05/9 = 0.0056 significance level (Bonferroni adjustment). All variables are significantly different across segments at a < 0.000 significance level using ANOVA, Kruskal-Wallis or Chi Square tests; ARMD – Age-Related Macular Degeneration; CHF – Congestive Heart Failure; COPD – Chronic Obstructive Pulmonary Disease; CRF – Chronic Renal Failure